Q702
MC220806: Phase I Study Evaluating the Efficacy of CSF1R and TAM Receptor or Inhibition in Hematologic Malignancies With Q702, a Small Molecular Inhibitor
Near Add Your Location
Sorting 2 by
Center of Excellence
Mayo Clinic (Arizona)
Phoenix, AZ
- Not yet accepting
Center of Excellence
Mayo Clinic (Rochester)
Rochester, MN
- Not yet accepting
Showing 1-2 of 2
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.